Preeclampsia: Insights into pathophysiological mechanisms and preventive strategies

This publication has 94 references indexed in Scilit:

• Genetic Risk Factors Associated With Preeclampsia and Hypertensive Disorders of Pregnancy
  JAMA Cardiology, 2023
• Aspirin Discontinuation at 24 to 28 Weeks’ Gestation in Pregnancies at High Risk of Preterm Preeclampsia
  JAMA, 2023
• Neurology of Preeclampsia and Related Disorders: an Update in Neuro-obstetrics
  Current Pain and Headache Reports, 2021
• The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre‐eclampsia: A pragmatic guide for first‐trimester screening and prevention
  International Journal of Gynecology & Obstetrics, 2019
• Obesity and Altered Aspirin Pharmacology
  Clinical Pharmacokinetics, 2017
• ASPRE trial: performance of screening for preterm pre‐eclampsia
  Ultrasound in Obstetrics & Gynecology, 2017
• Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial
  American Journal of Obstetrics and Gynecology, 2016
• Randomized controlled trial using low‐dose aspirin in the prevention of pre‐eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation
  Ultrasound in Obstetrics & Gynecology, 2003
• A Randomized Controlled Trial of Aspirin in Patients With Abnormal Uterine Artery Blood Flow
  Obstetrics & Gynecology, 1996
• Reference ranges of lipids and apolipoproteins in pregnancy
  European Journal of Obstetrics & Gynecology and Reproductive Biology, 1992